HOMEOSTATIC IRON REGULATOR GENE-RELATED HEREDITARY HEMOCHROMATOSIS

Clinical trials for HOMEOSTATIC IRON REGULATOR GENE-RELATED HEREDITARY HEMOCHROMATOSIS explained in plain language.

Never miss a new study

Get alerted when new HOMEOSTATIC IRON REGULATOR GENE-RELATED HEREDITARY HEMOCHROMATOSIS trials appear

Sign up with your email to follow new studies for HOMEOSTATIC IRON REGULATOR GENE-RELATED HEREDITARY HEMOCHROMATOSIS, keep track of the ones that matter, and come back to a personal dashboard instead of checking manually.

Our safety recommendation!

By submitting, you agree to our Terms of use

Trials to join now! 1

New drug trial aims to clear excess iron from the body

Disease control Recruiting now

This study is testing an investigational drug called vamifeport for adults with hereditary hemochromatosis, a condition where the body absorbs too much iron. The main goal is to see if vamifeport can safely reduce the amount of iron stored in the liver, which is measured by a spe…

Matched conditions: HOMEOSTATIC IRON REGULATOR GENE-RELATED HEREDITARY HEMOCHROMATOSIS

Phase: PHASE2 • Sponsor: CSL Behring • Aim: Disease control

Last updated Mar 23, 2026 15:14 UTC

HOMEOSTATIC IRON REGULATOR GENE-RELATED HEREDITARY HEMOCHROMATOSIS

Get alerted when new HOMEOSTATIC IRON REGULATOR GENE-RELATED HEREDITARY HEMOCHROMATOSIS trials appear

New drug trial aims to clear excess iron from the body